Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TURKOVAC Phase IIb in Healthy Adults
NCT05035238Phase 2Withdrawn
- Sponsor
- TÜSEB
- Start
- Oct 2021
- Primary completion
- Oct 2021
- Modality
- Whole Inactivated Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of turkovac in coronavirus disease 2019 (COVID-19), sponsored by TÜSEB. Planned start Oct 2021; status: withdrawn.
02
Drugs
turkovac
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05035238.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05035238.